Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heng-Gu-Gu-Shang-Yu-He-Ji for non-traumatic osteonecrosis of the femoral head
ChiCTR2300078938Phase 4Recruiting
- Sponsor
- Third Affiliated Hospital, Beijing University of Chinese Medicine
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Heng-Gu-Gu-Shang-Yu-He-Ji in osteonecrosis of the hip (2 arms), sponsored by Third Affiliated Hospital, Beijing University of Chinese Medicine. Primary endpoint: Visual analogue scale (VAS) pain score. Started Dec 2023; status: recruiting.
02
Drugs
Heng-Gu-Gu-Shang-Yu-He-Ji
03
Conditions
osteonecrosis of the hip
Beyond the preview
Go deeper on ChiCTR2300078938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078938.